254 related articles for article (PubMed ID: 19176395)
1. Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.
Kaur B; Cork SM; Sandberg EM; Devi NS; Zhang Z; Klenotic PA; Febbraio M; Shim H; Mao H; Tucker-Burden C; Silverstein RL; Brat DJ; Olson JJ; Van Meir EG
Cancer Res; 2009 Feb; 69(3):1212-20. PubMed ID: 19176395
[TBL] [Abstract][Full Text] [Related]
2. Histidine-rich glycoprotein modulates the anti-angiogenic effects of vasculostatin.
Klenotic PA; Huang P; Palomo J; Kaur B; Van Meir EG; Vogelbaum MA; Febbraio M; Gladson CL; Silverstein RL
Am J Pathol; 2010 Apr; 176(4):2039-50. PubMed ID: 20167858
[TBL] [Abstract][Full Text] [Related]
3. Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor.
Kaur B; Brat DJ; Devi NS; Van Meir EG
Oncogene; 2005 May; 24(22):3632-42. PubMed ID: 15782143
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.
Kang X; Xiao X; Harata M; Bai Y; Nakazaki Y; Soda Y; Kurita R; Tanaka T; Komine F; Izawa K; Kunisaki R; Setoyama M; Nishimori H; Natsume A; Sunamura M; Lozonshi L; Saitoh I; Tokino T; Asano S; Nakamura Y; Tani K
Cancer Gene Ther; 2006 Apr; 13(4):385-92. PubMed ID: 16244591
[TBL] [Abstract][Full Text] [Related]
5. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Tanaka T; Cao Y; Folkman J; Fine HA
Cancer Res; 1998 Aug; 58(15):3362-9. PubMed ID: 9699667
[TBL] [Abstract][Full Text] [Related]
6. The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus.
Fujii K; Kurozumi K; Ichikawa T; Onishi M; Shimazu Y; Ishida J; Chiocca EA; Kaur B; Date I
Cancer Gene Ther; 2013 Aug; 20(8):437-44. PubMed ID: 23827879
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.
Hardcastle J; Kurozumi K; Dmitrieva N; Sayers MP; Ahmad S; Waterman P; Weissleder R; Chiocca EA; Kaur B
Mol Ther; 2010 Feb; 18(2):285-94. PubMed ID: 19844198
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
9. ABT-510, a modified type 1 repeat peptide of thrombospondin, inhibits malignant glioma growth in vivo by inhibiting angiogenesis.
Anderson JC; Grammer JR; Wang W; Nabors LB; Henkin J; Stewart JE; Gladson CL
Cancer Biol Ther; 2007 Mar; 6(3):454-62. PubMed ID: 17384534
[TBL] [Abstract][Full Text] [Related]
10. A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1.
Cork SM; Kaur B; Devi NS; Cooper L; Saltz JH; Sandberg EM; Kaluz S; Van Meir EG
Oncogene; 2012 Dec; 31(50):5144-52. PubMed ID: 22330140
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1.
Zhu D; Hunter SB; Vertino PM; Van Meir EG
Cancer Res; 2011 Sep; 71(17):5859-70. PubMed ID: 21724586
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1.
Hsu SC; Volpert OV; Steck PA; Mikkelsen T; Polverini PJ; Rao S; Chou P; Bouck NP
Cancer Res; 1996 Dec; 56(24):5684-91. PubMed ID: 8971176
[TBL] [Abstract][Full Text] [Related]
13. Effects of tumor suppressor gene (p53) on brain tumor angiogenesis and expression of angiogenic modulators.
Tse V; Yung Y; Santarelli JG; Juan D; Hsiao M; Haas M; Harsh G; Silverberg G
Anticancer Res; 2004; 24(1):1-10. PubMed ID: 15015569
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics.
Reiher FK; Volpert OV; Jimenez B; Crawford SE; Dinney CP; Henkin J; Haviv F; Bouck NP; Campbell SC
Int J Cancer; 2002 Apr; 98(5):682-9. PubMed ID: 11920636
[TBL] [Abstract][Full Text] [Related]
15. LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.
Ren B; Best B; Ramakrishnan DP; Walcott BP; Storz P; Silverstein RL
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1197-208. PubMed ID: 27013613
[TBL] [Abstract][Full Text] [Related]
16. BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy.
Bolyard C; Meisen WH; Banasavadi-Siddegowda Y; Hardcastle J; Yoo JY; Wohleb ES; Wojton J; Yu JG; Dubin S; Khosla M; Xu B; Smith J; Alvarez-Breckenridge C; Pow-Anpongkul P; Pichiorri F; Zhang J; Old M; Zhu D; Van Meir EG; Godbout JP; Caligiuri MA; Yu J; Kaur B
Clin Cancer Res; 2017 Apr; 23(7):1809-1819. PubMed ID: 27852701
[No Abstract] [Full Text] [Related]
17. Antiangiogenic activity of endostatin inhibits C6 glioma growth.
Peroulis I; Jonas N; Saleh M
Int J Cancer; 2002 Feb; 97(6):839-45. PubMed ID: 11857365
[TBL] [Abstract][Full Text] [Related]
18. The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression.
Bernard H; Garmy-Susini B; Ainaoui N; Van Den Berghe L; Peurichard A; Javerzat S; Bikfalvi A; Lane DP; Bourdon JC; Prats AC
Oncogene; 2013 Apr; 32(17):2150-60. PubMed ID: 22733133
[TBL] [Abstract][Full Text] [Related]
19. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
[TBL] [Abstract][Full Text] [Related]
20. Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.
Pisati F; Belicchi M; Acerbi F; Marchesi C; Giussani C; Gavina M; Javerzat S; Hagedorn M; Carrabba G; Lucini V; Gaini SM; Bresolin N; Bello L; Bikfalvi A; Torrente Y
Cancer Res; 2007 Apr; 67(7):3054-63. PubMed ID: 17409412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
